Today(on 29th July), The Delhi High Court will rule today on a petition by doctors’ associations challenging Ramdev’s claim that ‘Coronil’ cures COVID-19. The petition, part of a 2021 lawsuit against Ramdev and Patanjali Ayurveda, follows Justice Bhambhani’s reserved decision from May 21.
Thank you for reading this post, don't forget to subscribe!
NEW DELHI: Today(on 29th July), The Delhi High Court is set to deliver its ruling concerning a petition from several doctors’ associations opposing Yoga guru Ramdev’s assertion that ‘Coronil’ is a “cure” for COVID-19. This petition is part of a 2021 lawsuit filed by these associations against Ramdev, his associate Acharya Balkrishna, and Patanjali Ayurveda. Justice Anup Jairam Bhambhani had reserved his decision on May 21 after hearing the arguments from the involved parties.
According to the lawsuit, Ramdev made “unsubstantiated claims” regarding ‘Coronil’ being a cure for COVID-19, contrary to the license granted to the drug for merely being an “immuno-booster”.
The senior counsel representing the doctors argued for a directive to prevent the defendants, Ramdev and others, from making any further such statements. The lawsuit was initiated by the Resident Doctors’ Association of the All India Institute of Medical Sciences at Rishikesh, Patna, and Bhubaneswar, as well as the Association of Resident Doctors, Post Graduate Institute of Medical Education & Research, Chandigarh; Union of Resident Doctors of Punjab (URDP); Resident Doctors’ Association, Lala Lajpat Rai Memorial Medical College, Meerut; and the Telangana Junior Doctors’ Association, Hyderabad.
These associations alleged that there was a “misinformation campaign” and a marketing strategy designed to boost the sales of Ramdev’s products, including ‘Coronil’, which was claimed to be an alternative treatment for COVID-19.
ALSO READ: Patanjali ads: Ramdev, Balkrishna tender unconditional apology before SC
On October 27, 2021, the high court had issued summons to Ramdev and others in relation to the lawsuit, noting that it was not frivolous and that a case for its institution was “definitely” made out.
During the proceedings, the plaintiffs emphasized the need for stringent actions to curb the spread of false information about medical treatments, especially in the context of a global pandemic. They pointed out that misleading claims about a cure could have severe implications for public health and safety.
The court’s decision is eagerly awaited as it will have significant implications for the regulation of medical claims made by alternative medicine practitioners and the accountability of influential public figures in promoting unverified treatments.
Ramdev, a prominent figure in the wellness and alternative medicine industry, has been at the center of several controversies concerning his claims about the efficacy of various herbal products. The outcome of this case could set a precedent for how such claims are scrutinized and regulated in the future.
